Glucagon Emergency Kit Now Available for Severe Hypoglycemia
Fresenius Kabi announced the launch of Glucagon Emergency Kit for the treatment of severe hypoglycemic episodes in adult and pediatric patients with diabetes.
Hypoglycemia
Severe Hypoglycemia Linked to Worse Cognition in Older Patients With T1D
Both recent severe hypoglycemia (SH) and lifetime SH are associated with worse cognition among older adults with type 1 diabetes.
Intermittently Scanned CGM May Reduce Hypoglycemia in T1D
Intermittently scanned continuous glucose monitoring results in higher treatment satisfaction among adults with type 1 diabetes.
Endocrine Society Releases Hypoglycemia Performance Measures for Older Adults
A new set of quality measures can help health care providers identify older adults with type 2 diabetes who are at increased risk for hypoglycemia.
Hypoglycemia Risk May Be Lower With Liver-Targeted Rapid-Acting Insulin Formulation
Hepatic-directed vesicle insulin, a novel liver-targeted rapid-acting insulin formulation for type 1 diabetes, is noninferior to insulin lispro for improvement of HbA1c and is associated with a lower hypoglycemia risk in some patients.
Ready-to-Use Liquid Glucagon Receives Approval for Severe Hypoglycemia
The Food and Drug Administration (FDA) has approved Gvoke (glucagon; Xeris Pharmaceuticals) for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes aged 2 years and older.
Tramadol and Methadone Linked to Risk for Hypoglycemia in Patients With, Without Diabetes
Patients taking the analgesic tramadol have an increased propensity for hypoglycemia compared to other opioids, according to a new analysis of the Food and Drug Administration’s Adverse Event Reporting Systems.
Diabetes, Ramadan, and Driving: Ensuring Patient Safety While Respecting Religious Autonomy
For many Muslims, fasting is an important part of individual and community life. Healthcare professionals should adopt a patient-centered approach to diabetes care during Ramadan.
Model Predicts Hypoglycemia Risk in Adults With Diabetes
A predictive model is presented for hypoglycemia that combines nearly all known and readily assessed risk factors for hypoglycemia such as infection, non-long-acting insulin, and dementia.
Less Intensive Diabetes Treatment May Benefit Patients at Risk for Hypoglycemia
Intensive glucose-lowering therapy is prevalent among U.S. adults with diabetes and results in hospitalizations and emergency department visits for hypoglycemia.
Next post in News
